Publication | Open Access
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
110
Citations
33
References
2019
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1